Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Roche CEO says new drugs will offset biosimilar incursions

Written by: | no-reply@reuters.com | Dated: Tuesday, March 13th, 2018

 

ZURICH (Reuters) – Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals’ copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.

Schwan’s outlook, delivered to shareholders at the company’s annual general meeting in Basel, confirms Roche’s previous guidance that 2018 sales will be flat or grow by a low-single-digit percentage compared to last year, amid incursions from so-called biosimilar drugs.

 

(Reporting by John Miller)

 

Reuters source:

https://www.reuters.com/article/us-roche-agm/roche-ceo-says-new-drugs-will-offset-biosimilar-incursions-idUSKCN1GP1BE?il=0

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom